• SE Asia (HQ)

    +65 3158 9940

  • Australia

    1300 798 820

  • New Zealand

    +64 9801 0299

December 2019 - ST – Onconova Therapeutics Partnership

ST partners with US-based Onconova Therapeutics, acquiring exclusive rights to market Rigosertib in Australia and New Zealand